Drugmaker CEO vows to cut prices after raising $13.50 pill to $750
A failed hedge fund manager who was vilified mercilessly on social media after overnight raising the price of an anti-malarial drug from $13.50 a pill to $750, has heard the public’s outrage — and said...
View ArticleOf course, $750 pill costs $900 in New York City
Almost everything costs more in New York — including a life-saving anti-malarial drug that shot up from $13.50 a pill to $750 overnight, sparking a nationwide outcry over price gouging. A day after...
View ArticleWhy people don’t trust drug makers
When former hedge-fund manager and current Turing Pharmaceuticals chief executive Martin Shkreli hiked the price of his generic anti-parasitic drug pyrimethamine from $13.50 to $750 per pill, he...
View ArticleSchneiderman probes drug maker over $750-a-pop pill
New York Attorney General Eric Schneiderman’s office is questioning a pharmaceutical company criticized last month for sharply increasing the price of treatment for a deadly parasitic infection....
View ArticleValeant shares fall on federal probe into drug pricing
Valeant Pharmaceuticals International shares tumbled as much as 9 percent Thursday morning after it disclosed that federal prosecutors were probing it over drug pricing, distribution and patient...
View ArticleWalgreens nears deal to buy rival Rite Aid
The largest US drugstore chain is looking to get “Rite-sized,” which means a lot bigger. Walgreens Boots Alliance announced a $17.2 billion all-cash deal on Tuesday to acquire Rite Aid, the...
View ArticleMom and pop ran $15M oxy ring out of pharmacies: prosecutors
This mom-and-pop pharmacy was selling more than just greeting cards and junk food — it was the home base for one of the biggest illegal prescription pill rings in New York history, authorities said...
View ArticleCVS, Express Scripts deliver blow to Valeant’s drug plan
Valeant’s clever plan to get its high-priced drugs paid for through specialty pharmacy Philidor RX Services is all but dead. The three largest US pharmacy-benefit managers — CVS Caremark, Express...
View ArticleValeant cutting ties with troubled Philidor
Valeant Pharmaceuticals, whose use of specialty pharmacies to get its high-price drugs dispensed to consumers over less expensive generics has raised a storm of controversy, backed away from the heat...
View ArticleBill Ackman spends 4 hours defending Valeant investment
Maybe it wasn’t the cold room so much as the chilly reception from investors. Hedge fund mogul Bill Ackman, who complained it was “freezing” in his conference room, held a marathon call Friday to...
View ArticlePharmacy accidentally gave kids bipolar pills instead of candy
A worker at a Canadian pharmacy accidentally gave out out bipolar medication to trick-or-treaters instead of candy, according to a report. The mix-up unfolded after a woman unknowingly dropped her...
View ArticleSenate panel probes Valeant, three others for drug price hikes
The bad news for Valeant Pharmaceuticals keeps on coming. A bipartisan Senate probe into the controversy over pricey pharmaceutical drugs gave Valeant shares another drubbing Wednesday. The Senate...
View ArticleScary masked thugs stick up Queens pharmacy for pills
Three masked crooks stuck-up a Queens pharmacy on Tuesday afternoon and made off with Xanax, Oxycodone and other prescription pills, authorities said. “Don’t move if you want to live!” one of the...
View ArticleBill Ackman hints at possible Valeant Pharmaceuticals sale
Embattled Valeant Pharmaceuticals may be coming around to the idea of selling itself. Hedge fund mogul Bill Ackman, who has lost more than $2 billion on his Valeant investment, wrote in an e-mail that...
View ArticleValeant CEO forced to sell shares to repay $100M loan
Valeant’s plunging stock has put the squeeze on CEO Michael Pearson. Pearson was forced to sell 1.3 million Valeant shares Thursday to repay a $100 million personal loan he had secured from Goldman...
View ArticleEmbattled Valeant CEO admits to ‘painful learning experience’
Cutting ties with a controversial specialty pharmacy will hurt Valeant Pharmaceuticals International Inc. in the short term, the company’s chief executive said Tuesday. As of last week, Philidor Rx...
View ArticleOf course, $750 pill costs $900 in New York City
Almost everything costs more in New York — including a life-saving anti-malarial drug that shot up from $13.50 a pill to $750 overnight, sparking a nationwide outcry over price gouging. A day after...
View ArticleWhy people don’t trust drug makers
When former hedge-fund manager and current Turing Pharmaceuticals chief executive Martin Shkreli hiked the price of his generic anti-parasitic drug pyrimethamine from $13.50 to $750 per pill, he...
View ArticleSchneiderman probes drug maker over $750-a-pop pill
New York Attorney General Eric Schneiderman’s office is questioning a pharmaceutical company criticized last month for sharply increasing the price of treatment for a deadly parasitic infection....
View ArticleValeant shares fall on federal probe into drug pricing
Valeant Pharmaceuticals International shares tumbled as much as 9 percent Thursday morning after it disclosed that federal prosecutors were probing it over drug pricing, distribution and patient...
View Article
